The World Health Organization’s director has warned that the current Ebola outbreak in the Democratic Republic of Congo could surpass the deadliest outbreak in history, which occurred between 2014 and 2016. According to reports, the outbreak, officially declared on May 15, has already recorded over 4,300 confirmed cases and more than 2,000 deaths. The situation is escalating rapidly, with new infections being reported daily, raising concerns among health officials and international organizations. The outbreak, caused by the Bundibugyo strain of the Ebola virus, has been traced back to February, according to preliminary findings. However, initial diagnoses were misclassified as malaria or typhus, delaying effective containment measures. Dr. Mohamed Janabi, the WHO director for Africa, noted during a press conference in Bunia, near the epicenter of the outbreak, that while efforts are underway to control the spread, the virus continues to pose a serious threat. He emphasized that the current outbreak could potentially exceed previous records, including the 2014–2016 epidemic in West Africa, which claimed nearly 11,000 lives. The Bundibugyo strain, though less common than other Ebola variants, remains highly lethal. It has previously triggered outbreaks in 2007 and 2012, yet there is currently no approved vaccine or treatment specifically targeting this variant. British regulators have recently authorized early trials of a potential vaccine developed by researchers at the University of Oxford, using technology similar to that used in the production of the COVID-19 vaccine. Other research groups are also working on vaccines against the Bundibugyo strain, none of which have reached clinical trial stages yet. The WHO is supporting separate clinical testing in the DRC, aiming to determine whether two existing antiviral treatments can improve survival rates. Despite these efforts, the response faces challenges due to ongoing instability in the region, which limits access to affected areas. As a result, healthcare workers estimate they are reaching only around 30% of infected individuals or those who have fallen ill. Ebola is a rare but deadly viral disease, with symptoms appearing between two and 21 days after infection. Initial signs resemble those of influenza or malaria, including fever, headache, and fatigue. As the illness progresses, patients may experience vomiting, diarrhea, and eventually organ failure. The virus spreads through direct contact with bodily fluids such as blood or vomit, making close personal interactions particularly risky. The current outbreak has raised alarms globally, with WHO Director-General Tedros Adhanom Ghebreyesus warning that the epidemic could become the deadliest in history. In a recent statement, he highlighted that the current rate of transmission could surpass past outbreaks. Humanitarian aid worker Tom Fletcher of the United Nations described the situation as one where Ebola claims a life every 30 minutes in the DRC. This alarming pace underscores the urgency of finding effective interventions and improving public awareness. Health authorities in the DRC reported on Sunday that 101 new cases had been identified in the last 24 hours, bringing the total number of confirmed cases to 4,945. While the official declaration of the outbreak was made on May 15, some experts believe the virus may have been circulating for at least three months before detection. Misdiagnosis initially hindered efforts to contain the spread, highlighting the need for improved diagnostic tools and rapid response mechanisms. As the situation evolves, the focus remains on controlling the outbreak and developing targeted medical solutions. With no immediate cure or vaccine available, the challenge lies in managing the crisis effectively and preventing further loss of life. International collaboration and local community engagement will play crucial roles in mitigating the impact of this ongoing health emergency.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter